{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:30Z","timestamp":1786982250628,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Life Oasis Charity Service Center","award":["HXKT20221019"],"award-info":[{"award-number":["HXKT20221019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-023-03255-w","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T12:03:04Z","timestamp":1689940984000},"page":"398-413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K\/AKT pathway inactivation"],"prefix":"10.1007","volume":"26","author":[{"given":"Yajun","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-0371","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"3255_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299\u2013311.","journal-title":"Lancet"},{"key":"3255_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"3255_CR3","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543\u201350.","DOI":"10.1038\/nature13385"},{"key":"3255_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12859-020-03691-3","volume":"21","author":"T Zengin","year":"2020","unstructured":"Zengin T, Onal-Suzek T. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma. BMC Bioinformatics. 2020;21:368.","journal-title":"BMC Bioinformatics"},{"key":"3255_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature22334","volume":"545","author":"T Tammela","year":"2017","unstructured":"Tammela T, Sanchez-Rivera FJ, Cetinbas NM, Wu K, Joshi NS, Helenius K, et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature. 2017;545:355\u20139.","journal-title":"Nature"},{"key":"3255_CR6","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1080\/21655979.2021.1972078","volume":"12","author":"J Song","year":"2021","unstructured":"Song J, Sun Y, Cao H, Liu Z, Xi L, Dong C, et al. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma. Bioengineered. 2021;12:5932\u201349.","journal-title":"Bioengineered"},{"key":"3255_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12967-019-02173-2","volume":"17","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhang Z, Yu Z. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. J Transl Med. 2019;17:423.","journal-title":"J Transl Med"},{"key":"3255_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11:2285.","journal-title":"Nat Commun"},{"key":"3255_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.478","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Zhang K, Zhi Y, Wu Y, Chen B, Bai J, et al. Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway. Clin Transl Med. 2021;11: e478.","journal-title":"Clin Transl Med"},{"key":"3255_CR10","first-page":"6192187","volume":"2018","author":"V Jurisic","year":"2018","unstructured":"Jurisic V, Obradovic J, Pavlovic S, Djordjevic N. Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation. Anal Cell Pathol (Amst). 2018;2018:6192187.","journal-title":"Anal Cell Pathol (Amst)"},{"key":"3255_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.21037\/tlcr.2016.06.04","volume":"5","author":"DB Costa","year":"2016","unstructured":"Costa DB. Kinase inhibitor-responsive genotypes in EGFR mutated lung adenocarcinomas: moving past common point mutations or indels into uncommon kinase domain duplications and rearrangements. Transl Lung Cancer Res. 2016;5:331\u20137.","journal-title":"Transl Lung Cancer Res"},{"key":"3255_CR12","doi-asserted-by":"publisher","first-page":"1973241","DOI":"10.1155\/2020\/1973241","volume":"2020","author":"V Jurisic","year":"2020","unstructured":"Jurisic V, Vukovic V, Obradovic J, Gulyaeva LF, Kushlinskii NE, Djordjevic N. EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis. J Oncol. 2020;2020:1973241.","journal-title":"J Oncol"},{"key":"3255_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3892\/ol.2022.13649","volume":"25","author":"J Obradovic","year":"2023","unstructured":"Obradovic J, Todosijevic J, Jurisic V. Side effects of tyrosine kinase inhibitors therapy in patients with non-small cell lung cancer and associations with EGFR polymorphisms: A systematic review and meta-analysis. Oncol Lett. 2023;25:62.","journal-title":"Oncol Lett"},{"key":"3255_CR14","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.18632\/aging.203318","volume":"13","author":"B Ling","year":"2021","unstructured":"Ling B, Liao X, Tang Q, Ye G, Bin X, Wang J, et al. MicroRNA-106b-5p inhibits growth and progression of lung adenocarcinoma cells by downregulating IGSF10. Aging (Albany NY). 2021;13:18740\u201356.","journal-title":"Aging (Albany NY)"},{"key":"3255_CR15","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1038\/s41467-018-05023-9","volume":"9","author":"H Ishii","year":"2018","unstructured":"Ishii H, Vodnala SK, Achyut BR, So JY, Hollander MC, Greten TF, et al. miR-130a and miR-145 reprogram Gr-1(+)CD11b(+) myeloid cells and inhibit tumor metastasis through improved host immunity. Nat Commun. 2018;9:2611.","journal-title":"Nat Commun"},{"key":"3255_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"3255_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"3255_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccell.2015.12.005","volume":"29","author":"J Hu","year":"2016","unstructured":"Hu J, Sun T, Wang H, Chen Z, Wang S, Yuan L, et al. MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. Cancer Cell. 2016;29:49\u201360.","journal-title":"Cancer Cell"},{"key":"3255_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/carcin\/bgab121","volume":"43","author":"H Li","year":"2022","unstructured":"Li H, Zhao S, Chen X, Feng G, Chen Z, Fan S. MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3. Carcinogenesis. 2022;43:288\u201396.","journal-title":"Carcinogenesis"},{"key":"3255_CR20","first-page":"6446150","volume":"2022","author":"Q Shi","year":"2022","unstructured":"Shi Q, Ju JG. Circ_0001998 Regulates the Proliferation, Invasion, and Apoptosis of Lung Adenocarcinoma via Sponging miR-145. Evid Based Complement Alternat Med. 2022;2022:6446150.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3255_CR21","doi-asserted-by":"crossref","unstructured":"Lin R, Li GS, Gan XY, Peng JX, Feng Y, Wang LT, et al. The clinical significance and mechanism of microRNA-22\u20133p targeting TP53 in lung adenocarcinoma. Technol Health Care. 2023;","DOI":"10.3233\/THC-220494"},{"key":"3255_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10529-017-2290-9","volume":"39","author":"D Mo","year":"2017","unstructured":"Mo D, Yang D, Xiao X, Sun R, Huang L, Xu J. MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin. Biotechnol Lett. 2017;39:701\u201310.","journal-title":"Biotechnol Lett"},{"key":"3255_CR23","first-page":"667","volume":"68","author":"DJ Ma","year":"2021","unstructured":"Ma DJ, Zhou XY, Qin YZ, Tian ZH, Liu HS, Li SQ. MiR-22-3p Expression is down-regulated in lung adenocarcinoma. Acta Biochim Pol. 2021;68:667\u201372.","journal-title":"Acta Biochim Pol"},{"key":"3255_CR24","doi-asserted-by":"publisher","first-page":"9549287","DOI":"10.1155\/2021\/9549287","volume":"2021","author":"F Deng","year":"2021","unstructured":"Deng F, Xu Z, Zhou J, Zhang R, Gong X. ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma. Comput Math Methods Med. 2021;2021:9549287.","journal-title":"Comput Math Methods Med"},{"key":"3255_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s12094-018-02012-8","volume":"41","author":"P Chen","year":"2019","unstructured":"Chen P, Gu YY, Ma FC, He RQ, Li ZY, Zhai GQ, et al. Expression levels and cotargets of miRNA1263p and miRNA1265p in lung adenocarcinoma tissues: Alphan exploration with RTqPCR, microarray and bioinformatic analyses. Oncol Rep. 2019;41:939\u201353.","journal-title":"Oncol Rep"},{"key":"3255_CR26","first-page":"71","volume":"10","author":"X Qin","year":"2016","unstructured":"Qin X, Wan Y, Wang S, Xue M. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2. Drug Des Devel Ther. 2016;10:71\u20139.","journal-title":"Drug Des Devel Ther"},{"key":"3255_CR27","doi-asserted-by":"publisher","first-page":"33486","DOI":"10.1073\/pnas.2007991117","volume":"117","author":"JP Hoj","year":"2020","unstructured":"Hoj JP, Mayro B, Pendergast AM. The ABL2 kinase regulates an HSF1-dependent transcriptional program required for lung adenocarcinoma brain metastasis. Proc Natl Acad Sci U S A. 2020;117:33486\u201395.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3255_CR28","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1007\/s10620-018-5111-7","volume":"63","author":"Y Liu","year":"2018","unstructured":"Liu Y, Shao C, Zhu L, Jiang S, Li G, Zhang W, et al. High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer. Dig Dis Sci. 2018;63:2294\u2013300.","journal-title":"Dig Dis Sci"},{"key":"3255_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12931-020-01587-7","volume":"21","author":"J Zeng","year":"2020","unstructured":"Zeng J, Yang X, Yang L, Li W, Zheng Y. Thymosin beta10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K\/Akt pathway in lung adenocarcinoma. Respir Res. 2020;21:328.","journal-title":"Respir Res"},{"key":"3255_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41419-020-02858-3","volume":"11","author":"J Liang","year":"2020","unstructured":"Liang J, Li H, Han J, Jiang J, Wang J, Li Y, et al. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K\/AKT pathway. Cell Death Dis. 2020;11:614.","journal-title":"Cell Death Dis"},{"key":"3255_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.554759","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Sui Z, Zhang H, Wang Y, Yu Z. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. Front Oncol. 2020;10: 554759.","journal-title":"Front Oncol"},{"key":"3255_CR32","doi-asserted-by":"publisher","first-page":"71881","DOI":"10.18632\/oncotarget.17985","volume":"8","author":"Z Kun-Peng","year":"2017","unstructured":"Kun-Peng Z, Xiao-Long M, Chun-Lin Z. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget. 2017;8:71881\u201393.","journal-title":"Oncotarget"},{"issue":"3421\u201334","key":"3255_CR33","volume":"29","author":"JP Hoj","year":"2019","unstructured":"Hoj JP, Mayro B, Pendergast AM. A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis. Cell Rep. 2019;29(3421\u201334): e8.","journal-title":"Cell Rep"},{"key":"3255_CR34","doi-asserted-by":"crossref","unstructured":"Miricescu D, Totan A, Stanescu S, II, Badoiu SC, Stefani C, Greabu M. PI3K\/AKT\/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. Int J Mol Sci. 2020;22:","DOI":"10.3390\/ijms22010173"},{"key":"3255_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118513","volume":"262","author":"S Fattahi","year":"2020","unstructured":"Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K\/AKT\/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci. 2020;262: 118513.","journal-title":"Life Sci"},{"key":"3255_CR36","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.7150\/ijbs.59939","volume":"17","author":"D Zhang","year":"2021","unstructured":"Zhang D, Jiang Q, Ge X, Shi Y, Ye T, Mi Y, et al. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK\/c-Jun pathway. Int J Biol Sci. 2021;17:2622\u201332.","journal-title":"Int J Biol Sci"},{"key":"3255_CR37","doi-asserted-by":"crossref","first-page":"153303382199000","DOI":"10.1177\/1533033821990009","volume":"20","author":"G Zhang","year":"2021","unstructured":"Zhang G, Xia M, Guo J, Huang Y, Huang J, Wei K, et al. microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2. Technol Cancer Res Treat. 2021;20:1533033821990009.","journal-title":"Technol Cancer Res Treat"},{"key":"3255_CR38","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/bloodadvances.2017000547","volume":"1","author":"KG Roberts","year":"2017","unstructured":"Roberts KG, Yang YL, Payne-Turner D, Lin W, Files JK, Dickerson K, et al. Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. Blood Adv. 2017;1:1657\u201371.","journal-title":"Blood Adv"},{"key":"3255_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89647","volume":"1","author":"JJ Gu","year":"2016","unstructured":"Gu JJ, Rouse C, Xu X, Wang J, Onaitis MW, Pendergast AM. Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis. JCI Insight. 2016;1: e89647.","journal-title":"JCI Insight"},{"key":"3255_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153459","volume":"223","author":"C Hu","year":"2021","unstructured":"Hu C, Wu J, Wang L, Liu X, Da B, Liu Y, et al. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8. Pathol Res Pract. 2021;223: 153459.","journal-title":"Pathol Res Pract"},{"key":"3255_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/mc.23159","volume":"59","author":"D Tao","year":"2020","unstructured":"Tao D, Zhang Z, Liu X, Zhang Z, Fu Y, Zhang P, et al. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2. Mol Carcinog. 2020;59:353\u201364.","journal-title":"Mol Carcinog"},{"key":"3255_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13019-022-01788-9","volume":"17","author":"C Yang","year":"2022","unstructured":"Yang C, Huang T, Liang Y, Xue Y, Liang Y, Wei X, et al. CTHRC1 targeted by miR-30a-5p regulates cell adhesion, invasion and migration in lung adenocarcinoma. J Cardiothorac Surg. 2022;17:46.","journal-title":"J Cardiothorac Surg"},{"key":"3255_CR43","doi-asserted-by":"crossref","unstructured":"Li Y, Zhao J, Zhang W, Wang A, Jiao M, Cai X, et al. LINC02535\/miR-30a-5p\/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- kappa B signaling pathway. Cell Cycle. 2022;1\u201316.","DOI":"10.1080\/15384101.2022.2101336"},{"key":"3255_CR44","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/carcin\/bgab051","volume":"42","author":"K Tao","year":"2021","unstructured":"Tao K, Liu J, Liang J, Xu X, Xu L, Mao W. Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2. Carcinogenesis. 2021;42:1056\u201367.","journal-title":"Carcinogenesis"},{"key":"3255_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12957-021-02339-7","volume":"19","author":"X Chen","year":"2021","unstructured":"Chen X, Zhang W, Xu X. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K\/AKT\/mTOR pathway. World J Surg Oncol. 2021;19:232.","journal-title":"World J Surg Oncol"},{"key":"3255_CR46","doi-asserted-by":"crossref","unstructured":"Lee CH, Hung PF, Liu KJ, Chung HL, Yang WC, Hsu KC, et al. LDOC1 Suppresses Microbe-Induced Production of IL-1beta in Human Normal and Cancerous Oral Cells through the PI3K\/Akt\/GSK-3beta Axis. Cancers (Basel). 2020;12:","DOI":"10.3390\/cancers12113148"},{"key":"3255_CR47","first-page":"2125656","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Wang L, Zhou X, Luo X, Liu K, Jiang E, et al. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K\/AKT Pathway. Biomed Res Int. 2020;2020:2125656.","journal-title":"Biomed Res Int"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03255-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03255-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03255-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:25:32Z","timestamp":1706142332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03255-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["3255"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03255-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Ethics Committee of Affiliated Hospital of Nantong University in accordance with the <i>Declaration of Helsinki<\/i>. Written informed consent was obtained from all the participants. All experimental operations were approved by the Laboratory Animal Ethics Committee of Affiliated Hospital of Nantong University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}